2 unknown, 1 completed, 1 not yet recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Pneumonitis, Interstitial: new trials by email Literature Review of Pneumonitis, Interstitial trials Research Report on Pneumonitis, Interstitial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP Nebulized hUCMSC-Exos, Nebulized normal saline - Pneumonitis, Interstitial, Immune Checkpoint Inhibitors (ICIs) | Phase 1 / Phase 2 | Not yet recruiting | Zhou Chengzhi | 40 | 2026-04-01 | 2026-05-20 |
| TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia Tofacitinib, Hydroxychloroquine - Pneumonitis, Interstitial, COVID-19 | Phase 2 | Unknown | Università Politecnica delle Marche | 116 | 2020-06-01 | 2020-05-15 |
| A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade Immune checkpoint blockade, Targeted therapy, Radiotherapy - Pneumonitis, Interstitial, Immunotherapy | Unknown | Universitaire Ziekenhuizen KU Leuven | 60 | 2020-02-01 | 2024-07-01 | |
| Rituximab in Interstitial Pneumonitis Rituximab, Zr-89-rituximab immuno PET/CT - Lung Diseases, Interstitial, Pneumonitis, Interstitial | Phase 2 / Phase 3 | Completed | Human Adams | 20 | 2014-09-01 | 2018-05-31 |
Lung Diseases, Interstitial (4) · COVID-19 (1)
Lung Diseases (4) · Respiratory Tract Diseases (4) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Chromatin Immunoprecipitation Sequencing (1) · Hydroxychloroquine (1) · Immune Checkpoint Inhibitors (1) · Radiotherapy (1) · Rituximab (1) · durvalumab (1) · pembrolizumab (1) · tofacitinib (1)
Human Adams (1) · Universitaire Ziekenhuizen KU Leuven (1) · Università Politecnica delle Marche (1) · Zhou Chengzhi (1)
Belgium (1) · Netherlands (1)
Els Wauters, MD, PhD (1) · J C Grutters, MD, PhD (1)